Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Elevance Health Inc

ELV

Elevance Health Inc

Elevance Health Inc historical holders

total: 18

Sound Shore Management Elevance Health Inc transactions over time

Total transactions:
20
New positions:
4
Sold out:
3
Added:
4
Reduced:
9
Held since:
2026 Q2
Held for:
1 quarter
Latest activity:
2026 Q2
Harry Burn has been an institutional investor in Elevance Health Inc (ELV) since 2014 Q4. According to 2026 Q2 report, Harry Burn holds 243,452 shares with a market value of roughly $94.15M representing 2.90% of their equity portfolio. The fund/company first acquired ELV in 2014 Q4, initially purchasing about 1.35M shares. Harry Burn later completely sold out the position and reinvested in ELV again in 2026 Q2. Since the initial investment, Sound Shore Management has made 19 more transactions in this position.

Does Harry Burn still hold ELV?

Yes, Harry Burn continues to hold Elevance Health Inc (ELV). According to their 2026 Q2 report, they maintain a position of 243,452 shares valued at approximately $94.15M, representing 2.90% of their equity portfolio.

When did Harry Burn first invest in ELV?

Harry Burn first invested in Elevance Health Inc (ELV) in 2014 Q4 at the reported quarter-end price of $125.67 per share, acquiring 1,345,042 shares in their initial purchase.

What is Harry Burn's average cost basis for ELV?

Based on historical transaction data, Harry Burn's estimated cost basis for Elevance Health Inc (ELV) is approximately $386.73 per share. This represents their average reported price* across all buy transactions.

Has Harry Burn reinvested in ELV after selling?

Yes, Harry Burn has shown renewed interest in Elevance Health Inc (ELV). After completely selling their position, they reinitiated an investment in 2026 Q2, demonstrating continued conviction in this ticker.

Estimated cost basis*

Weighted AVG buy price:
$386.73

ELV transactions history by Sound Shore Management

20 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q2
2.90%
243,452
$386.73
$94,150,192
new
+2.9%
2024 Q4
0.00%
0
$520.00
-100% (-119,497)
-2.02%
2024 Q3
2.02%
119,497
$520.00
$62,138,440
-2.11% (-2,572)
-0.04%
2024 Q2
2.21%
122,069
$541.86
$66,144,309
-21.06% (-32,574)
-0.55%
2024 Q1
2.51%
154,643
$518.54
$80,188,581
+3.14% (+4,713)
+0.08%
2023 Q4
2.45%
149,930
$471.56
$70,700,991
-0.16% (-247)
-0%
2023 Q3
2.50%
150,177
$435.42
$65,390,069
+27.93% (+32,790)
+0.55%
2023 Q2
1.92%
117,387
$444.29
$52,153,871
new
+1.92%
2022 Q3
0.00%
0
$482.58
-100% (-125,137)
-2.21%
2022 Q2
2.21%
125,137
$482.58
$60,389,000
-21.32% (-33,912)
-0.48%
2022 Q1
2.27%
$491.22
-27.19% (-59,404)
2021 Q4
2.81%
$463.54
-9.85% (-23,876)
2021 Q3
2.55%
$372.80
+12.14% (+26,238)
2021 Q2
2.30%
$381.80
-2.74% (-6,095)
2021 Q1
2.33%
$358.95
+0.33% (+740)
2020 Q4
2.12%
$321.09
new
2015 Q3
0.00%
$164.14
-100% (-987,841)
2015 Q2
2.61%
$164.14
-7.14% (-75,940)
2015 Q1
2.63%
$154.41
-20.91% (-281,261)
2014 Q4
2.66%
$125.67
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.